Acute Medical Oncology Admissions During the COVID-19 Pandemic
Patients in Ireland logged shorter hospital stays and had fewer emergency department visits during the COVID-19 pandemic.
News
Germline Factors Affect Molecular Response to Treatment for Polycythemia Vera
Germline polymorphisms can affect response to treatment in people with polycythemia vera.
BCMA-Directed CAR T Cell Therapy Gets Priority Review for Multiple Myeloma
The BLA is supported by data from the open-label, single-arm phase 2 KarMMa study.
Patient Perception Survey Shows Lack of Education, Assessment of Cancer-Related Fatigue
Results of a perception survey revealed major deficits in education, screening, and treatment among patients with cancer.
PARP Inhibitor Prolongs Overall Survival in mCRPC
An overall survival advantage with olaparib was particularly observed among patients with BRCA1 or BRCA2 alterations.
Venetoclax With 10-day Decitabine May Induce High Activity in High-Risk Acute Myeloid Leukemia
Patients with newly diagnosed AML who are ineligible for intensive chemotherapy may benefit from a 10-day course of decitabine with venetoclax.
Disparities of Colorectal Liver Metastases Treatment and Survival Among Ethnic Groups in California
A retrospective cohort study explored whether the low rate of resection for colorectal liver metastases is associated with lower survival rates among Black patients with CRC.
Recall of Specific Types of Breast Implants and Tissue Expanders Has Far-Reaching Impact on Patients With Breast Cancer
In Japan, insurance coverage for breast implantation is limited to procedures using Allergen-manufactured products.
Follicular Lymphoma: Interactions With Surrounding Cells to Identify Therapeutic Targets
Characterizing gene expression profiles of FL cells from intrafollicular and extrafollicular regions may help to identify future therapeutic targets.
Two-Drug Combo Superior to Sunitinib as First-Line Therapy for Advanced RCC
Compared with sunitinib alone, nivolumab plus cabozantinib therapy was associated with a 49% decreased risk for progression and 40% decreased risk for death.
Neoadjuvant Chemo May Improve Overall Survival in UTUC
Survival was significantly improved in patients with greater disease burden.
Greater Subcutaneous Fat Improves mCRPC Treatment Response
In a study of men with mCRPC receiving chemotherapy and maximal androgen ablation, those who had an objective response to treatment had a significantly higher subcutaneous adipose tissue index than those who did not.
Nurse Educational Workshop Improves Communications With Patients About Sexual Health
Oncology nurses’ knowledge of sexual health concerns and barriers to conversations between nurses and patients regarding sexual health were improved with a nurse-education workshop.
Immunotherapy Plus Radiotherapy After Surgery Improves OS in Tumors With Brain Metastases, Study Finds
Study found adding immunotherapy to radiotherapy significantly improved OS after definitive surgery for primary tumor in patients with brain metastasis.
Genomic Instability Predicts Risk of Progression for Barrett Esophagus
Genomic copy number instability predicted the risk of disease progression among patients with Barrett esophagus years beforehand.
Venetoclax With a Hypomethylating Agent Effective in Treatment-Naive or Relapsed/Refractory Acute Myeloid Leukemia
Regardless of genotype, venetoclax with a hypomethylating agent yields strong response and survival outcomes among patients with treatment-naive or R/R AML.
Frailty Linked to Poor Postsurgical Outcomes in Patients With Ovarian Cancer
In a review of data from the Nationwide Readmissions Database, researchers found that women with ovarian cancer classified as frail were at higher risk for need of intensive care, nonroutine discharge, and readmissions after surgery.
Rivaroxaban May Be a Suitable Alternative to Low-Molecular Weight Heparin in Cancer-Associated Thrombosis
Among some patients with cancer-associated thrombosis, rivaroxaban may be a viable alternative to low-molecular-weight heparin.
EAU Issues Updated UTUC Guidelines
The 2020 update highlights the importance of accurate diagnosis of upper tract urothelial carcinoma, risk stratification, close follow-up of patients receiving kidney-sparing management, and other key aspects of care.
Uncommon Mutation in CLL Associated With More Favorable Prognostic Factors
Patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who had an L265P MYD88 mutation were uncommon and had distinct features.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Web Exclusives
